Stock Analysis

Inspiration Healthcare Group Full Year 2024 Earnings: UK£0.088 loss per share (vs UK£0.004 profit in FY 2023)

AIM:IHC
Source: Shutterstock

Inspiration Healthcare Group (LON:IHC) Full Year 2024 Results

Key Financial Results

  • Revenue: UK£37.6m (down 8.7% from FY 2023).
  • Net loss: UK£6.03m (down from UK£272.0k profit in FY 2023).
  • UK£0.088 loss per share (down from UK£0.004 profit in FY 2023).
revenue-and-expenses-breakdown
AIM:IHC Revenue and Expenses Breakdown August 7th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Inspiration Healthcare Group Earnings Insights

The primary driver behind last 12 months revenue was the United Kingdom segment contributing a total revenue of UK£17.7m (47% of total revenue). Notably, cost of sales worth UK£19.7m amounted to 52% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to UK£18.7m (78% of total expenses). Explore how IHC's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Medical Equipment industry in the United Kingdom.

Performance of the British Medical Equipment industry.

The company's shares are down 5.6% from a week ago.

Risk Analysis

It is worth noting though that we have found 4 warning signs for Inspiration Healthcare Group (2 make us uncomfortable!) that you need to take into consideration.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.